Skip to main content
Top
Published in: Abdominal Radiology 8/2019

01-08-2019 | Magnetic Resonance Imaging | Hepatobiliary

Anastomosing hemangioma of the liver: a case series

Authors: Brendan Lunn, Saba Yasir, Dora Lam-Himlin, Christine O. Menias, Michael S. Torbenson, Sudhakar K. Venkatesh

Published in: Abdominal Radiology | Issue 8/2019

Login to get access

Abstract

Purpose

To report imaging and pathologic features of five pathologically proven anastomosing hemangiomas of the liver (AHL).

Methods

A retrospective review for AHL was conducted using our institutional database from 6/2004 to 3/2018. Histology proven AHL with radiologic imaging available for review were included. A total of five patients who met our criteria were identified from our institutional database. Computed tomography, ultrasound, and magnetic resonance imaging findings, including location, size, attenuation/signal intensity, enhancement characteristics, and additional imaging data were reviewed. The clinical and pathological data were also reviewed.

Results

The imaging characteristics of AHL are variable, but features such as peripheral or diffuse hyperintensity on diffusion weighted imaging, arterial hyperenhancement without globular interrupted enhancement, and persistent enhancement without complete filling in the delayed phases were more characteristic of AHL. Imaging also demonstrated a lack of aggressive features.

Conclusions

AHL present a diagnostic dilemma as they can mimic more malignant lesions, such as angiosarcoma, both on imaging and at pathology. While the imaging characteristics of AHL are variable, there are some features which can help distinguish AHL from other liver lesions. When the diagnosis of anastomosing hemangioma is known, the management of choice is primarily surveillance, as intervention can cause unnecessary morbidity, and no degeneration to malignancy has been identified to date.
Literature
8.
go back to reference Zhao M, Li C, Zheng J, Sun K (2013) Anastomosing hemangioma of the kidney: a case report of a rare subtype of hemangioma mimicking angiosarcoma and review of the literature. International journal of clinical and experimental pathology 6 (4):757-765PubMedPubMedCentral Zhao M, Li C, Zheng J, Sun K (2013) Anastomosing hemangioma of the kidney: a case report of a rare subtype of hemangioma mimicking angiosarcoma and review of the literature. International journal of clinical and experimental pathology 6 (4):757-765PubMedPubMedCentral
Metadata
Title
Anastomosing hemangioma of the liver: a case series
Authors
Brendan Lunn
Saba Yasir
Dora Lam-Himlin
Christine O. Menias
Michael S. Torbenson
Sudhakar K. Venkatesh
Publication date
01-08-2019

Other articles of this Issue 8/2019

Abdominal Radiology 8/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.